Cosmeceuticals: A review of their use for aging and photoaged skin

Cosmetic Dermatology

Volumn 19, Issue 7, 2006, Pages 479-484

  Dahiya, Anjali ^a   Romano, John F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYACID; ADAPALENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ARBUTIN; ASCORBIC ACID; AZELAIC ACID; BETA HYDROXYACID; CITRIC ACID; COSMETIC; EPIDERMAL GROWTH FACTOR; GLABRIDIN; GLYCOLIC ACID; GLYCYLHISTIDYLLYSINE; GROWTH FACTOR; KOJIC ACID; LACTIC ACID; MATRIX PROTEIN; NICOTINAMIDE; PEPTIDE; PLATELET DERIVED GROWTH FACTOR; RETINOIC ACID; RETINOL; SALICYLIC ACID; TARTARIC ACID; TAZAROTENE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALYLGLYCYLVALYLALANYLPROLYLGLYCINE; VASCULOTROPIN;

ANTIOXIDANT ACTIVITY; DRUG ACTIVITY; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; PHOTOAGING; PRESCRIPTION; REVIEW; RISK BENEFIT ANALYSIS; SKIN CARE; SYSTEMATIC REVIEW; WRINKLE;

EID: 33746016271     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Kligman D. Cosmeceuticals. Dermatol Clin. 2000;18:609-615.
2. Brody HJ. Relevance of cosmeceuticals to the dermatologic surgeon. Dermatol Surg. 2005;31:796-798.
3. Lupo MP. Peptides and proteins. In: Draelos ZD, ed. Cosmeceuticals. 1st ed. Philadelphia, Pa: Elsevier Saunders; 2005:119-124.
4. Ditre CM, Griffin TD, Murphy GF, et al. Effects of alpha hydroxy acids on photoaged skin: a pilot clinical, histologic, and ultrastructural study. J Am Acad Dermatol. 1996;34:187-195.
5. Varani J, Warner RL, Gharaee-Kermani M, et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol. 2000;114:480-486.
6. Bissett DL, Oblong JE, Berge CA. Niacinamide: a B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005;31: 860-865.
7. Burke KE. Nutritional antioxidants. In: Draelos ZD, ed. Cosmeceuticals. 1st ed. Philadelphia, Pa: Elsevier Saunders; 2005:125-132.
8. Fitzpatrick RE. Endogenous growth factors as cosmeceuticals. Dermatol Surg. 2005;31:827-831.
9. Rendon MI, Gaviria JI. Review of skin-lightening agents. Dermatol Surg. 2005;31:886-889.
10. Ditre CM. Exfoliants: AHAs and BHAs. In: Draelos ZD, ed. Cosmeceuticals. 1st ed. Philadelphia, Pa: Elsevier Saunders; 2005:111-118.
11. Corcuff P, Fiat F, Gracia AM, et al. Hydroxy acid induced-desquamation of the human stratum corneum: a comparative ultrastructural study. Presented at: 19th International Federation Society of Chemists Congress; October, 1996; Sydney, Australia.
12. Kligman AM. The compatibility of combinations of GA and tretinoin in acne and in photoaged facial skin. J Geriatr Dermatol 1995;3:25A-28A.
13. Woodley DT, Zelickson AS, Briggaman RA, et al. Treatment of photoaged skin with topical tretinoin increases epidermal-dermal anchoring fibrils, a preliminary report. JAMA. 1990;263:3057-3059.
14. Olsen EA, Katz I, Levine N, et al. Tretinoin emollient cream: a new therapy for photodamaged skin. J Am Acad Dermatol 1992;26:215-224.
15. Kang S, Duell EA, Fisher GJ, et al. Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. J Invest Dermatol. 1995;105:549-556.
16. Draelos ZD. Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream. Dermatol Surg. 2005;31:799-804.
17. Farris PK. Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions. Dermatol Surg. 2005;31:814-817.
18. Traikovich SS. Use of topical ascorbic acid and its effects on photodamaged skin topography. Arch Otolaryngol Head Neck Surg. 1999;125:1091-1098.
19. Humbert PG, Haftek M, Creidi P, et al. Topical ascorbic acid on photoaged skin, clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo: Exp Dermatol 2003;12:237-244.
20. Fitzpatrick RE, Rostan EF. Double blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg. 2002;28:231-236.
21. Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147:20-31.
22. Bissett DL, Oblong JE, Saud A, et al. Topical niacinamide provides skin aging appearance benefits while enhancing barrier function. J Clin Dermatol 2003;32:S9-S18.
23. Matts PJ, Oblong JE, Bissett DL. A review of the range of effects of niacinamide in human skin. Int Fed Soc Cosmet Chem Mag. 2002;5:285-289.
24. Thiele JJ, Hsieh SN, Ekanayake-Mudiyanselage S. Vitamin E: critical review of its current use in cosmetic and clinical dermatology. Dermatol Surg. 2005;31:805-813.
25. Beitner H. Randomized, placebo-controlled, double blind study on the clinical efficacy of a cream containing 5% alpha-lipoic acid related to photoaging of facial skin. Br J Dermatol 2003;149:841-849.
26. Hoppe U, Bergemann J, Diembeck W, et al. Coenzyme Q10, a cutaneous antioxidant and energizer. Biofactors. 1999;9:371-378.
27. Wrinkle reduction study 2003. In: Eucerin Q10 Product Compendium. Wilton, Conn: Beiersdorf Inc; 2003:11.
28. Hsu S. Green tea and the skin. J Am Acad Dermatol. 2005;52: 1049-1059.
29. Chiu AE, Chan JL, Kern DG, et al. Double-blinded, placebo-controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin. Dermatol Surg. 2005;31:855-860.
30. Rattan SI, Clark BF. Kinetin delays the onset of aging characteristics in human fibroblasts. Biochem Biophys Res Commun. 1994;201:665-672.
31. McCullough JL, Weinstein GD. Clinical study of safety and efficacy of using Kinetin 0.1% (Kinerase®) to treat photodamaged skin. Cosmet Dermatol. September 2002;15:29-32.
32. Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987; 262:5592-5595.
33. Wei H, Saladi R, Lu Y, et al. Isoflavone genistein: photoprotection and clinical implications in dermatology. J Nutr. 2003(11 suppl 1);133:3811S-3819S.
34. Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003;5:25-34.
35. Kamoun A, Landeau JM, Godeau G, et al. Growth stimulation of human skin fibroblasts by elastin-derived peptides. Cell Adhes Commun. 1995;3:273-281.
36. Tajima S, Wachi H, Uemera Y, et al. Modulation by elastin peptide VGVAPG of cell proliferation and elastin expression in human skin fibroblasts. Arch Dermatol Res. 1997;289:489-492.
37. Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002;24:303.
38. Piamphongsant T. Treatment of melasma: a review with personal experience. Int J Dermatol 1998;37:897-903.
39. Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol. 1991;30: 893-895.
40. Sarkar R, Bhalla MA, Kanwar AJ. A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients. Dermatology. 2002;205:249-254.
41. Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg 1999;25: 282-284.
42. Holloway VL. Ethnic cosmetic products. Dermatol Clin. 2003; 21:743-749.
43. Riley PA. Mechanism of pigment cell toxicity produced by hydroxyanisole. J Pathol 1970;101:163-169.